Loading…

B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia

Immune complexes consisting of heparin, platelet factor 4 (PF4), and PF4/heparin-reactive antibodies are central to the pathogenesis of heparin-induced thrombocytopenia (HIT). It is as yet unclear what triggers the initial induction of pathogenic antibodies. We identified B cells in peripheral blood...

Full description

Saved in:
Bibliographic Details
Published in:Blood 2014-02, Vol.123 (6), p.931-934
Main Authors: Zheng, Yongwei, Wang, Alexander W., Yu, Mei, Padmanabhan, Anand, Tourdot, Benjamin E., Newman, Debra K., White, Gilbert C., Aster, Richard H., Wen, Renren, Wang, Demin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c529t-da486d844290aecdfee4dc7a1f50c1bd17f103352c0a1351be71e3c1a31075033
cites cdi_FETCH-LOGICAL-c529t-da486d844290aecdfee4dc7a1f50c1bd17f103352c0a1351be71e3c1a31075033
container_end_page 934
container_issue 6
container_start_page 931
container_title Blood
container_volume 123
creator Zheng, Yongwei
Wang, Alexander W.
Yu, Mei
Padmanabhan, Anand
Tourdot, Benjamin E.
Newman, Debra K.
White, Gilbert C.
Aster, Richard H.
Wen, Renren
Wang, Demin
description Immune complexes consisting of heparin, platelet factor 4 (PF4), and PF4/heparin-reactive antibodies are central to the pathogenesis of heparin-induced thrombocytopenia (HIT). It is as yet unclear what triggers the initial induction of pathogenic antibodies. We identified B cells in peripheral blood of healthy adults that produce PF4/heparin-specific antibodies following in vitro stimulation with proinflammatory molecules containing deoxycytosine-deoxyguanosine (CpG). Similarly, B cells from unmanipulated wild-type mice produced PF4/heparin-specific antibodies following in vitro or in vivo CpG stimulation. Thus, both healthy humans and mice possess preexisting inactive/tolerant PF4/heparin-specific B cells. The findings suggest that breakdown of tolerance leads to PF4/heparin-specific B-cell activation and antibody production in patients developing HIT. Consistent with this concept, mice lacking protein kinase Cδ (PKCδ) that are prone to breakdown of B-cell tolerance produced anti-PF4/heparin antibodies spontaneously. Therefore, breakdown of tolerance can lead to PF4/heparin-specific antibody production, and B-cell tolerance may play an important role in HIT pathogenesis. •B-cell tolerance plays a critical role in controlling production of PF4/heparin-specific antibodies.
doi_str_mv 10.1182/blood-2013-11-540781
format article
fullrecord <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3916881</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120360535</els_id><sourcerecordid>S0006497120360535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-da486d844290aecdfee4dc7a1f50c1bd17f103352c0a1351be71e3c1a31075033</originalsourceid><addsrcrecordid>eNp9kN1qGzEQhUVoaFynbxDCvoDSGf141zeB1LRpIZCb5C4gtNKsrbKWFq0c8Nt3HbdpepOrYThzzsx8jF0gXCE24kvbp-S5AJQckWsFdYMnbIZaNBxAwAc2A4AFV8saz9incfwFgEoK_ZGdCSV1XUucsaev3FHfVyX1lG10VGVa73pbaKyGnPzOlZBilbrKxhLa5MMkOLsbQ1xXGxpsDpGHOM2Rr8omp22b3L6kgWKw5-y0s_1In__UOXv8_u1h9YPf3d_-XN3ccafFsnBvVbPwjVJiCZac74iUd7XFToPD1mPdIUiphQOLUmNLNZJ0aCVCrSdlzq6PucOu3ZJ3FEu2vRly2Nq8N8kG878Sw8as07ORS1w0DU4B6hjgchrHTN2rF8EcaJsX2uZAe-rNkfZku3y799X0F--_w2j6_jlQNqMLNFH2IZMrxqfw_obfQgyUqQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia</title><source>ScienceDirect®</source><creator>Zheng, Yongwei ; Wang, Alexander W. ; Yu, Mei ; Padmanabhan, Anand ; Tourdot, Benjamin E. ; Newman, Debra K. ; White, Gilbert C. ; Aster, Richard H. ; Wen, Renren ; Wang, Demin</creator><creatorcontrib>Zheng, Yongwei ; Wang, Alexander W. ; Yu, Mei ; Padmanabhan, Anand ; Tourdot, Benjamin E. ; Newman, Debra K. ; White, Gilbert C. ; Aster, Richard H. ; Wen, Renren ; Wang, Demin</creatorcontrib><description>Immune complexes consisting of heparin, platelet factor 4 (PF4), and PF4/heparin-reactive antibodies are central to the pathogenesis of heparin-induced thrombocytopenia (HIT). It is as yet unclear what triggers the initial induction of pathogenic antibodies. We identified B cells in peripheral blood of healthy adults that produce PF4/heparin-specific antibodies following in vitro stimulation with proinflammatory molecules containing deoxycytosine-deoxyguanosine (CpG). Similarly, B cells from unmanipulated wild-type mice produced PF4/heparin-specific antibodies following in vitro or in vivo CpG stimulation. Thus, both healthy humans and mice possess preexisting inactive/tolerant PF4/heparin-specific B cells. The findings suggest that breakdown of tolerance leads to PF4/heparin-specific B-cell activation and antibody production in patients developing HIT. Consistent with this concept, mice lacking protein kinase Cδ (PKCδ) that are prone to breakdown of B-cell tolerance produced anti-PF4/heparin antibodies spontaneously. Therefore, breakdown of tolerance can lead to PF4/heparin-specific antibody production, and B-cell tolerance may play an important role in HIT pathogenesis. •B-cell tolerance plays a critical role in controlling production of PF4/heparin-specific antibodies.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2013-11-540781</identifier><identifier>PMID: 24357731</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Animals ; Antibody Formation - immunology ; Anticoagulants - adverse effects ; Anticoagulants - metabolism ; B-Lymphocytes - immunology ; B-Lymphocytes - metabolism ; B-Lymphocytes - pathology ; Brief Report ; Cells, Cultured ; Heparin - adverse effects ; Heparin - metabolism ; Humans ; Immune Tolerance ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Platelet Factor 4 - immunology ; Platelet Factor 4 - metabolism ; Prognosis ; Protein Kinase C-delta - physiology ; Thrombocytopenia - chemically induced ; Thrombocytopenia - immunology ; Thrombocytopenia - metabolism ; Transfusion Medicine</subject><ispartof>Blood, 2014-02, Vol.123 (6), p.931-934</ispartof><rights>2014 American Society of Hematology</rights><rights>2014 by The American Society of Hematology 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-da486d844290aecdfee4dc7a1f50c1bd17f103352c0a1351be71e3c1a31075033</citedby><cites>FETCH-LOGICAL-c529t-da486d844290aecdfee4dc7a1f50c1bd17f103352c0a1351be71e3c1a31075033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006497120360535$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,3548,27923,27924,45779</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24357731$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zheng, Yongwei</creatorcontrib><creatorcontrib>Wang, Alexander W.</creatorcontrib><creatorcontrib>Yu, Mei</creatorcontrib><creatorcontrib>Padmanabhan, Anand</creatorcontrib><creatorcontrib>Tourdot, Benjamin E.</creatorcontrib><creatorcontrib>Newman, Debra K.</creatorcontrib><creatorcontrib>White, Gilbert C.</creatorcontrib><creatorcontrib>Aster, Richard H.</creatorcontrib><creatorcontrib>Wen, Renren</creatorcontrib><creatorcontrib>Wang, Demin</creatorcontrib><title>B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia</title><title>Blood</title><addtitle>Blood</addtitle><description>Immune complexes consisting of heparin, platelet factor 4 (PF4), and PF4/heparin-reactive antibodies are central to the pathogenesis of heparin-induced thrombocytopenia (HIT). It is as yet unclear what triggers the initial induction of pathogenic antibodies. We identified B cells in peripheral blood of healthy adults that produce PF4/heparin-specific antibodies following in vitro stimulation with proinflammatory molecules containing deoxycytosine-deoxyguanosine (CpG). Similarly, B cells from unmanipulated wild-type mice produced PF4/heparin-specific antibodies following in vitro or in vivo CpG stimulation. Thus, both healthy humans and mice possess preexisting inactive/tolerant PF4/heparin-specific B cells. The findings suggest that breakdown of tolerance leads to PF4/heparin-specific B-cell activation and antibody production in patients developing HIT. Consistent with this concept, mice lacking protein kinase Cδ (PKCδ) that are prone to breakdown of B-cell tolerance produced anti-PF4/heparin antibodies spontaneously. Therefore, breakdown of tolerance can lead to PF4/heparin-specific antibody production, and B-cell tolerance may play an important role in HIT pathogenesis. •B-cell tolerance plays a critical role in controlling production of PF4/heparin-specific antibodies.</description><subject>Adult</subject><subject>Animals</subject><subject>Antibody Formation - immunology</subject><subject>Anticoagulants - adverse effects</subject><subject>Anticoagulants - metabolism</subject><subject>B-Lymphocytes - immunology</subject><subject>B-Lymphocytes - metabolism</subject><subject>B-Lymphocytes - pathology</subject><subject>Brief Report</subject><subject>Cells, Cultured</subject><subject>Heparin - adverse effects</subject><subject>Heparin - metabolism</subject><subject>Humans</subject><subject>Immune Tolerance</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Platelet Factor 4 - immunology</subject><subject>Platelet Factor 4 - metabolism</subject><subject>Prognosis</subject><subject>Protein Kinase C-delta - physiology</subject><subject>Thrombocytopenia - chemically induced</subject><subject>Thrombocytopenia - immunology</subject><subject>Thrombocytopenia - metabolism</subject><subject>Transfusion Medicine</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kN1qGzEQhUVoaFynbxDCvoDSGf141zeB1LRpIZCb5C4gtNKsrbKWFq0c8Nt3HbdpepOrYThzzsx8jF0gXCE24kvbp-S5AJQckWsFdYMnbIZaNBxAwAc2A4AFV8saz9incfwFgEoK_ZGdCSV1XUucsaev3FHfVyX1lG10VGVa73pbaKyGnPzOlZBilbrKxhLa5MMkOLsbQ1xXGxpsDpGHOM2Rr8omp22b3L6kgWKw5-y0s_1In__UOXv8_u1h9YPf3d_-XN3ccafFsnBvVbPwjVJiCZac74iUd7XFToPD1mPdIUiphQOLUmNLNZJ0aCVCrSdlzq6PucOu3ZJ3FEu2vRly2Nq8N8kG878Sw8as07ORS1w0DU4B6hjgchrHTN2rF8EcaJsX2uZAe-rNkfZku3y799X0F--_w2j6_jlQNqMLNFH2IZMrxqfw_obfQgyUqQ</recordid><startdate>20140206</startdate><enddate>20140206</enddate><creator>Zheng, Yongwei</creator><creator>Wang, Alexander W.</creator><creator>Yu, Mei</creator><creator>Padmanabhan, Anand</creator><creator>Tourdot, Benjamin E.</creator><creator>Newman, Debra K.</creator><creator>White, Gilbert C.</creator><creator>Aster, Richard H.</creator><creator>Wen, Renren</creator><creator>Wang, Demin</creator><general>Elsevier Inc</general><general>American Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20140206</creationdate><title>B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia</title><author>Zheng, Yongwei ; Wang, Alexander W. ; Yu, Mei ; Padmanabhan, Anand ; Tourdot, Benjamin E. ; Newman, Debra K. ; White, Gilbert C. ; Aster, Richard H. ; Wen, Renren ; Wang, Demin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-da486d844290aecdfee4dc7a1f50c1bd17f103352c0a1351be71e3c1a31075033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Animals</topic><topic>Antibody Formation - immunology</topic><topic>Anticoagulants - adverse effects</topic><topic>Anticoagulants - metabolism</topic><topic>B-Lymphocytes - immunology</topic><topic>B-Lymphocytes - metabolism</topic><topic>B-Lymphocytes - pathology</topic><topic>Brief Report</topic><topic>Cells, Cultured</topic><topic>Heparin - adverse effects</topic><topic>Heparin - metabolism</topic><topic>Humans</topic><topic>Immune Tolerance</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Platelet Factor 4 - immunology</topic><topic>Platelet Factor 4 - metabolism</topic><topic>Prognosis</topic><topic>Protein Kinase C-delta - physiology</topic><topic>Thrombocytopenia - chemically induced</topic><topic>Thrombocytopenia - immunology</topic><topic>Thrombocytopenia - metabolism</topic><topic>Transfusion Medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheng, Yongwei</creatorcontrib><creatorcontrib>Wang, Alexander W.</creatorcontrib><creatorcontrib>Yu, Mei</creatorcontrib><creatorcontrib>Padmanabhan, Anand</creatorcontrib><creatorcontrib>Tourdot, Benjamin E.</creatorcontrib><creatorcontrib>Newman, Debra K.</creatorcontrib><creatorcontrib>White, Gilbert C.</creatorcontrib><creatorcontrib>Aster, Richard H.</creatorcontrib><creatorcontrib>Wen, Renren</creatorcontrib><creatorcontrib>Wang, Demin</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zheng, Yongwei</au><au>Wang, Alexander W.</au><au>Yu, Mei</au><au>Padmanabhan, Anand</au><au>Tourdot, Benjamin E.</au><au>Newman, Debra K.</au><au>White, Gilbert C.</au><au>Aster, Richard H.</au><au>Wen, Renren</au><au>Wang, Demin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2014-02-06</date><risdate>2014</risdate><volume>123</volume><issue>6</issue><spage>931</spage><epage>934</epage><pages>931-934</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>Immune complexes consisting of heparin, platelet factor 4 (PF4), and PF4/heparin-reactive antibodies are central to the pathogenesis of heparin-induced thrombocytopenia (HIT). It is as yet unclear what triggers the initial induction of pathogenic antibodies. We identified B cells in peripheral blood of healthy adults that produce PF4/heparin-specific antibodies following in vitro stimulation with proinflammatory molecules containing deoxycytosine-deoxyguanosine (CpG). Similarly, B cells from unmanipulated wild-type mice produced PF4/heparin-specific antibodies following in vitro or in vivo CpG stimulation. Thus, both healthy humans and mice possess preexisting inactive/tolerant PF4/heparin-specific B cells. The findings suggest that breakdown of tolerance leads to PF4/heparin-specific B-cell activation and antibody production in patients developing HIT. Consistent with this concept, mice lacking protein kinase Cδ (PKCδ) that are prone to breakdown of B-cell tolerance produced anti-PF4/heparin antibodies spontaneously. Therefore, breakdown of tolerance can lead to PF4/heparin-specific antibody production, and B-cell tolerance may play an important role in HIT pathogenesis. •B-cell tolerance plays a critical role in controlling production of PF4/heparin-specific antibodies.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24357731</pmid><doi>10.1182/blood-2013-11-540781</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2014-02, Vol.123 (6), p.931-934
issn 0006-4971
1528-0020
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3916881
source ScienceDirect®
subjects Adult
Animals
Antibody Formation - immunology
Anticoagulants - adverse effects
Anticoagulants - metabolism
B-Lymphocytes - immunology
B-Lymphocytes - metabolism
B-Lymphocytes - pathology
Brief Report
Cells, Cultured
Heparin - adverse effects
Heparin - metabolism
Humans
Immune Tolerance
Mice
Mice, Inbred C57BL
Mice, Knockout
Platelet Factor 4 - immunology
Platelet Factor 4 - metabolism
Prognosis
Protein Kinase C-delta - physiology
Thrombocytopenia - chemically induced
Thrombocytopenia - immunology
Thrombocytopenia - metabolism
Transfusion Medicine
title B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T10%3A30%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=B-cell%20tolerance%20regulates%20production%20of%20antibodies%20causing%20heparin-induced%20thrombocytopenia&rft.jtitle=Blood&rft.au=Zheng,%20Yongwei&rft.date=2014-02-06&rft.volume=123&rft.issue=6&rft.spage=931&rft.epage=934&rft.pages=931-934&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2013-11-540781&rft_dat=%3Celsevier_pubme%3ES0006497120360535%3C/elsevier_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c529t-da486d844290aecdfee4dc7a1f50c1bd17f103352c0a1351be71e3c1a31075033%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/24357731&rfr_iscdi=true